In a recent decision, the National Advertising Division (NAD) determined that Nanoceutical Solutions Inc. had failed to adequately substantiate efficacy and establishment claims for its product Nano Glutathione.
On February 6, the SAG-AFTRA National Board approved a new “Influencer Agreement” that covers certain “influencer-generated branded content” across all social media platforms and other digital channels.
New York’s brand-new automatic renewal law, SB 1475, went into effect this week, on February 9, 2021. The state joins dozens of others that have already enacted similar laws.
On January 21, the Children’s Advertising Review Unit announced a social media and photo editor app that has become well known to teens and tweens for the “VSCO girl” trend is not an online service that is either primarily or secondarily directed toward children as defined by the ...
The National Advertising Division (NAD) has recommended that Chobani LLC modify its “45% less sugar than other yogurts” claim for Chobani Less Sugar Greek Yogurt products to clearly communicate the basis of comparison and avoid implying that “other yogurts” include yogurt ...
A panel of the National Advertising Review Board (NARB) has recommended that Procter & Gamble (P&G) discontinue the claim that Tide purclean laundry detergent has “4x the cleaning power” of the leading plant-based detergent, Purex Natural Elements.
The Federal Trade Commission (FTC) is sending checks totaling $774,755 to 13,221 consumers who bought Synovia, a supplement advertised and sold by A.S. Research, LLC, as a treatment for arthritis and joint pain.
The Federal Trade Commission (FTC) has sent 28 warning letters to eyeglass prescribers warning them of potential violations of the FTC’s Ophthalmic Practice Rules, known as the Eyeglass Rule, which enables consumers to comparison shop for prescription eyeglasses.
The Federal Trade Commission (FTC) has sent warning letters to 20 more marketers warning them to stop making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus.
After a public comment period, the Federal Trade Commission (FTC) has approved a final agreement with Sunday Riley Modern Skincare, LLC, and its CEO, Sunday Riley.